Market Place
Sourcing Support
AbbVie Declares Quarterly Dividend
19 Jun 2026 //
PR NEWSWIRE
Turn Nonresponder Insights into Smarter Immunology Drug Strategy
18 Jun 2026 //
BIOSPACE
AbbVie Presents 9-Year Venclexta Data in First-Line CLL at EHA
12 Jun 2026 //
PRESS RELEASE
AbbVie Presents Data Across Blood Cancer Portfolio at EHA 2026
08 Jun 2026 //
PR NEWSWIRE
UK’s NICE backs AbbVie’s ovarian cancer drug Elahere
03 Jun 2026 //
REUTERS
EC Approves AbbVie`s Atogepant for Acute Migraine in Adults
02 Jun 2026 //
PRESS RELEASE
AbbVie to Present at Goldman Sachs Global Health Conference
02 Jun 2026 //
PR NEWSWIRE
AbbVie`s Venetoclax Get Label Expansion in Untreated CLL Leukemia
29 May 2026 //
PR NEWSWIRE
Abbvie’s Biologics Decnupaz Receives Approval in US
27 May 2026 //
FDA
US FDA Approves Abbvie`s Rare Blood Cancer Drug
27 May 2026 //
PRESS RELEASE
AbbVie Gets CHMP Backing for Maviret in Acute Hepatitis C
22 May 2026 //
PR NEWSWIRE
Abbvie, GSK Race Up Patient Reputation Leaderboard In the UK
22 May 2026 //
FIERCE PHARMA
Abbvie, Novartis Slash US Headcount
22 May 2026 //
BIOSPACE
Allergan Aesthetics Receives Positive CHMP Opinion for Boey
22 May 2026 //
PR NEWSWIRE
AbbVie Shows Next-Generation Breadth, Momentum at ASCO 2026
22 May 2026 //
PR NEWSWIRE
Abbvie Loses Patent Plea For Hep C Drug
19 May 2026 //
ECONOMICTIMES
AbbVie Appoints Kelly Sanderson Schrems as UK VP and GM
15 May 2026 //
PMLIVE
AbbVie to Present at BofA Securities Healthcare Conference
06 May 2026 //
PR NEWSWIRE
Amgen, AbbVie say IRA Negotiations Impacted Q1 Sales
06 May 2026 //
ENDPOINTS
AbbVie Presents Long-Term IBD Data at DDW 2026
05 May 2026 //
PRESS RELEASE
AbbVie Selects RIME as Quebec Recipient via adMare BioInnovations
30 Apr 2026 //
FIRSTWORD PHARMA
AbbVie Reports First-Quarter 2026 Financial Results
29 Apr 2026 //
PRESS RELEASE
AbbVie Seeks FDA Approval for RINVOQ in Severe Alopecia Areata
29 Apr 2026 //
PRESS RELEASE
Kestrel Therapeutics Launches Phase 1 KST-6051 Trial
28 Apr 2026 //
GLOBENEWSWIRE
EvolveImmune Hits Preclinical Milestone with AbbVie
28 Apr 2026 //
GLOBENEWSWIRE
Abbvie Acquires KRAS Target With Option To Purchase Kestrel
28 Apr 2026 //
BIOSPACE
Abbvie Seeks FDA Approval For SKYRIZI Subcutaneous Induction
27 Apr 2026 //
PRESS RELEASE
AbbVie Provides Update on TrenibotE BLA in the US
24 Apr 2026 //
PRESS RELEASE
AbbVie to build $1.4B manufacturing campus in North Carolina
23 Apr 2026 //
PRESS RELEASE
AbbVie, BioLabs Team Up for Life Sciences in Canada
20 Apr 2026 //
PRESS RELEASE
Nxera Pharma to Receive $10M Milestone from AbbVie
20 Apr 2026 //
GLOBENEWSWIRE
AbbVie launches ‘PSO Done’ Psoriasis Campaign
20 Apr 2026 //
FIERCE PHARMA
Forge Genetics Licenses Forge Editing For Pharma Applications
14 Apr 2026 //
PHARMIWEB
Erin Lichy Gets Real About Her Natrelle Breast Augmentation
14 Apr 2026 //
PRESS RELEASE
Haisco Inks Exclusive Pain Medicine License Deal With Abbvie
13 Apr 2026 //
PR NEWSWIRE
AbbVie to Showcase Phase 2 ELAHERE PSOC Data at SGO 2026
12 Apr 2026 //
PR NEWSWIRE
Abbvie Urges Rethink Of `Patient` Definition In 340B Lawsuit
09 Apr 2026 //
ENDPOINTS
BOTOX Supports Women Entrepreneurs via Confidence Campaign
08 Apr 2026 //
PR NEWSWIRE
BOTOX Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs
08 Apr 2026 //
PRESS RELEASE
AbbVie moves to close loopholes and strengthen accountability
08 Apr 2026 //
PRESS RELEASE
Allergan Third State-of-the-Art AMI Center Opens in Austin
07 Apr 2026 //
PRESS RELEASE
Anthropic Puts $400M Into Coefficient Bio Life Sciences
06 Apr 2026 //
BIOSPACE
Mission BioCapital Opens $4M 2026 Platinum Program Contest
02 Apr 2026 //
PR NEWSWIRE
AbbVie IBD Scholarship Program Marks 15 Years
02 Apr 2026 //
GLOBENEWSWIRE
Abbvie To Host First-Quarter 2026 Earnings Conference Call
31 Mar 2026 //
PR NEWSWIRE
Allergan Aesthetics Presents Repeat Trenibote Safety Data
30 Mar 2026 //
PR NEWSWIRE
Abbvie Showcases Advances In Immune-Mediated Skin Disease Care
27 Mar 2026 //
PRESS RELEASE
AbbVie Named Official Pharmaceutical Partner of League Baseball
24 Mar 2026 //
PRESS RELEASE
Allergan Aesthetics Unveils Evolved Approach via Global Survey
19 Mar 2026 //
PRESS RELEASE
Alloy Enters Into Agreement to Advance Novel Antibody Platform
17 Mar 2026 //
BUSSINESSWIRE
AbbVie CEO Robert Michael gets $32.5M payday in `25
10 Mar 2026 //
FIERCE PHARMA
AbbVie Reports Positive Ph1 Results For ABBV-295 Amylin Analog
10 Mar 2026 //
PRESS RELEASE
Abbvie Presents At Leerink Partners Healthcare Conference
03 Mar 2026 //
PR NEWSWIRE
Abbvie Reports Phase 3 Success For SKYRIZI In Crohn`s Disease
02 Mar 2026 //
PR NEWSWIRE
Abbvie To Present At TD Cowen Health Care Conference
24 Feb 2026 //
PR NEWSWIRE
AbbVie Earmarks $380M for 2 new API plants
24 Feb 2026 //
PRESS RELEASE
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Abbvie Declares Quarterly Dividend
19 Feb 2026 //
PRESS RELEASE
Abbvie Heads To `The Persistence Lab` For New Podcast Series
19 Feb 2026 //
FIERCE PHARMA
Abbvie Sues HHS, CMS Over Botox`s Inclusion In IRA Price Talks
12 Feb 2026 //
FIERCE PHARMA
